Somerville, Massachusetts-based Finch Therapeutics Group Inc, a microbiome therapeutics company, has raised $53 million in Series C financing. The investors included OCV Partners, Susquehanna International Group, Symbiosis LLC, the Trans-Pacific Technology Fund, Avenir Growth Capital, Morgan Noble, Shumway Capital and Willett Advisors.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.